Antibacterial, Antifungal, Antiviral Drug For Skin, (REVISI 2)
Antibacterial, Antifungal, Antiviral Drug For Skin, (REVISI 2)
Herri S. Sastramihardja
INTRODUCTION
Allergic Hypersensitivity
Adverse Effect
Indication
• Cutaneous Candidiasis
Adverse Efects
• Yellowish discolouration of skin & nails
Interactions
• Should not be used concurently with imidazole agents (Clotrimazole,
Econazole, Ketoconazole, Miconazole) because their effects may
counteract each other
CICLOPIROX OLAMINE
Indication
• Superficial dermatophyte infection
Adverse Effects
• Pruritus
• Worsening of clinical disease secondary to infection
IMIDAZOLE
Indication
• Superficial dermatophyte infections, cutaneous candidiasis, tinea
versicolor (All Imidazole antifungal agents)
• Clotrimazole & Miconazole also indicated for treatment of
vulvovaginal candidiasis
Adverse Effects
• Local reactions to Imidazole drugs include stinging, pruritus,
erythema, local irritation.
HALOPROGIN
Indication
• Superficial dermatophyte infections
• Tinea versicolor
Adverse Effects
• Local irritation
• Burning sensation
• Vesiculation
• Exacerbation of the lessions
NYSTATIN
Indication
• Cutaneous, oral, intstinal, vulvovaginal candidiasis
Adverse Effects
• Diarrhea, nausea, vomiting (association with large doses)
TOLNAFTATE
Indication
• Superficial dermatophyte infections,
• Tinea versicolor
• Not effective againts Candida
Adverse Effects
• Rarely cause irritation.
Hal 355
GRISEOFULVIN (=GF)
Indication:
• Dermatophyte infections of the skin, hair, and nails
• Effective against Epidermophyton, Microsporum, Trichophyton species
• Ieffective against Candida & Pityrosporeus orbiculare
Pharmacokinetics
• Microsize GF orally (1 Gr) C max= 2 µg/ml3; Tmax= 4-6 hours
• Reduction particle size Î absorption
• (1/2 dose VMS GF C plasma = MSGF
• Transported by sweat + transepidermal fluid to stratum corneum (4-6
hours after oral)
Contraindication & Warnings
• Allergic hypersensitivity
• Cross reactivity with Penicillin (derived Penicillin mold)
• Should not be used in porphiria or hepatic failure
• It’s safety on pregnancy is not established
Adverse Effects
• Headache, confusion
• Nausea, vomiting, diarrhea
• Photosensitivity
• Pheripheral neuritis
• Leukopenia & proteinuria (have been reported)
Interactions:
Indications
• Chronic mucocutaneous candidiasis
• Severe recalcitrant dermatophyte infections
• Chromomycosis
Pharmacokinetics
• Oral absorption requires an acidic gastric environment
• In achlorhydria, each tablet must be dissolved in 4 ml of 0,2
normal HCL prior to ingestion
KETOCONAZOLE
Adverse Effects
• Hepatocellular hepatotoxicity (1/10.000)
• Nausea, vomiting ( ↓with food),
• Gynecomastia, impotence, ↓testosterone levels (in dose of 800 mg/
day)
KETOCONAZOLE
Interactions
• Antacids, anticholinergic, H2 blockers (2 hours pre-K)
• Ketoconazole ↑anticoagulant effect of Coumarin
• Ketoconazole ↑blood level of Cyclosporine ↑nehrotoxicity
• Rifampin ↑metabolic clearance of Ketoconazole
TOPICAL ANTIVIRAL AGENTS
ACYCLOVIR
Indication
• Primary & recurrent Herpes simplex Infections (HSI)
• HSI in immunocompromised patients
Pharmacokinetics
• Systemic absorption following topical application is minimal
Adverse Effects
• Minimal for topical administration
Indications
• Condyloma acuminatum
• Verucca vulgaris
Adverse Effects
• Local irritation (common)
• severe ulceration of surrounding tissue
• Residual post inflmmatory hyperpigmentation
Preparation available & dosage
• Podophyllum Resin (Pod.Ben-25, Podofin, Podoben: 25% tincture)
• Used once weekly (for 3-5 weeks), thin layer, allow it to dry.
• Wash tincture 2-3 hours after initial application 6-8 hours after
subsequent applications
• Prescribing category: RX do not use in pregnant women
ANTIVIRAL SYSTEMIC AGENTS